Elastrin Therapeutics, Inc. is an innovative biotechnology company dedicated to creating groundbreaking therapies aimed at reversing cardiovascular diseases and reinstating elasticity in damaged tissues and organs. By addressing the genetic and environmental factors leading to the deterioration of elastin, the company seeks to enhance the quality of life for patients suffering from related health issues.
Company Values
Elastrin’s unique focus on the restoration of elastin integrity positions it as a potential leader in addressing root causes of cardiovascular ailments rather than merely treating symptoms.